Your browser doesn't support javascript.
loading
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
Scharenberg, Christian; Giai, Valentina; Pellagatti, Andrea; Saft, Leonie; Dimitriou, Marios; Jansson, Monika; Jädersten, Martin; Grandien, Alf; Douagi, Iyadh; Neuberg, Donna S; LeBlanc, Katarina; Boultwood, Jacqueline; Karimi, Mohsen; Jacobsen, Sten Eirik W; Woll, Petter S; Hellström-Lindberg, Eva.
Affiliation
  • Scharenberg C; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Giai V; Department of Medicine, Division of Hematology, Skaraborgs Hospital, Skövde, Sweden.
  • Pellagatti A; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Saft L; Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, and NIHR Biomedical Research Centre, Oxford, UK.
  • Dimitriou M; Department of Pathology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Jansson M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Jädersten M; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Grandien A; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Douagi I; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Neuberg DS; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • LeBlanc K; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Boultwood J; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Karimi M; Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, and NIHR Biomedical Research Centre, Oxford, UK.
  • Jacobsen SE; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Woll PS; Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Hellström-Lindberg E; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Haematologica ; 102(3): 498-508, 2017 03.
Article in En | MEDLINE | ID: mdl-27884971
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Chromosomes, Human, Pair 5 / Chromosome Deletion / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Chromosomes, Human, Pair 5 / Chromosome Deletion / Mutation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Sweden